IKT
#3209
Inhibikase Therapeutics, Inc. - Common Stock
2.3 9 USD
+0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+3.46%
Variación mensual
+9.13%
Variación en los últimos 6 meses
+23.83%
Cambio anual
+35.03%
Cierres anteriores
2.3 1
Open
2.3 9
Mínimo
2.3 7
Máximo
2.4 1
Volumen
219
Financials
- Market Capitalization 333.49 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.61
Relación precio/flujo de caja
54.94
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3192 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 5.69 USD | -0.87% | -16.93% | +25.05% | +39.46% | 337.90 M USD | ||
| 3194 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.70 USD | -0.27% | -2.63% | +3.06% | +79.61% | 336.65 M USD | ||
| 3244 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.43 USD | +0.56% | -0.18% | +6.47% | -1.81% | 328.31 M USD | ||
| 3249 |  IMRX Immuneering Corporation - Class A Common Stock | 4.85 USD | -2.81% | -7.27% | +16.87% | -14.01% | 313.78 M USD |